Executive Leadership Team

Nafiseh Jafari, PhD is Chief Science Officer at nRichDX. Nafiseh joined nRichDX in January 2020 and has over 10 years experience in life science research. She is a scientific leader with a passion for building and managing high performance teams. Nafiseh has managed multimillion dollar development projects leading to the successful creation and launch of multiple products. Her expertise in talent management and quality/design control systems make her a key member of the nRichDX team.

Immediately prior to joining nRichDX, Nafiseh was a Project Manager leading cross
functional teams at Abbott Diagnostics. She holds a B.S. degree in Chemistry from
Sharif University of Technology and earned her Ph.D. degree in Biochemistry and
Molecular Biology at Western Michigan University.

Tom Curtis is a life sciences marketing and commercial leader with more than 20 years of experience spanning genomics, biotechnology tools, and clinical and molecular diagnostics. He has held pivotal roles at industry leaders and high-growth start-ups including Human Genome Sciences, OriGene Technologies, QIAGEN, CBLPath, and Sonic Healthcare.

Tom has built strong brands and successfully launched multiple category-defining products, among them QIAGEN’s EZ1^® and QIAsymphony^® nucleic acid extraction platforms and CBLPath’s ThyroSeq^® Thyroid Genomic Classifier. He is known for building and developing high-performing teams and excels across strategic and tactical marketing, sales enablement, and commercial operations.

He holds a B.S. in Biochemistry with a minor in English from Virginia Tech and completed graduate-level marketing studies at Harvard Extension School.

Kamran Syed is Vice President of Sales at nRichDX. Kamran joined the team at nRichDX in January of 2021 and brings over 20 years of commercial experience with roles in Sales, Marketing, Sales Leadership, Business Development and Strategy at a myriad of leading Diagnostics and Life Science companies to include Abbott Laboratories, ThermoFIsher Scientific, Cepheid, Novartis (Genoptix Medical Laboratories), Quest Diagnostics, Cardinal Health, and Illumina. As a Commercial Leader, Kamran has led teams to consistently exceed multimillion dollar revenue and profit targets.

Kamran is a seasoned biotechnology commercial executive that is passionate about and exceptionally skilled in building high performance teams, market development, business development and sales and strategy execution, helping companies bring to market paradigm shifting molecular diagnostic and genomic technologies, and high medical value add therapies, which have the potential to transform how patient care is delivered.

Kamran holds a B.S. degree in Biology, with minors in Chemistry and Psychology from Loyola University of Chicago, and an MBA, with a focus in Healthcare Management from the University of Phoenix.

Mayer Saidian, PhD is Vice President of Research & Development for nRichDX.
Mayer joined nRichDX in early 2020 and brings over 15 years of
development experience in molecular biology and life sciences. Mayer is a
scientific leader with passion for breakthrough technologies and combining
cutting edge technologies and bringing them into the scientific and clinical
worlds.

Prior to joining nRichDX, Mayer was conducting multi-disciplinary and
international research at University of California, Irvine and Hebrew
University in Jerusalem to develop no-invasive methodologies to diagnose
internal diseases, such as diabetes, through the skin. Mayer used advanced
technologies and machine learning skills to perform this study.
Mayer holds B.S. and M.S. degrees in biology and chemistry and earned his
Ph.D. degree in Pharmacology at the Hebrew University in Jerusalem and
University of California, Irvine.